SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001176256-16-000479
Filing Date
2016-03-18
Accepted
2016-03-18 17:17:25
Documents
11
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015 auriniapharma40f.htm 40-F 26334
2 ANNUAL INFORMATION FORM FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015 exhibit99-1.htm EX-99.1 274953
3 AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2015 exhibit99-2.htm EX-99.2 426966
4 MANAGEMENT'S DISCUSSION AND ANALYSIS FOR THE YEAR ENDED DECEMBER 31, 2015 exhibit99-3.htm EX-99.3 181784
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT AUDITOR exhibit99-4.htm EX-99.4 2530
6 SOX 302 CERTIFICATIONS exhibit99-5.htm EX-99.5 17721
7 SOX 906 CERTIFICATIONS exhibit99-6.htm EX-99.6 4986
8 exhibit99-1x1x1.jpg GRAPHIC 197864
9 exhibit99-3x1x1.jpg GRAPHIC 190610
10 exhibit99-3x19x1.jpg GRAPHIC 6700
11 pwclogo.jpg GRAPHIC 5362
  Complete submission text file 0001176256-16-000479.txt   1488327
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 40-F | Act: 34 | File No.: 001-36421 | Film No.: 161516930
SIC: 2834 Pharmaceutical Preparations